News

Latest news

Hide mandatory notifications of trade

Mandatory Notification of Trade

Oslo 05.09.2014

Reference is made to the stock exchange notice published by Bionor Pharma ASA (“Bionor” or the “Company”) published at 07:30 CET today. Bionor announces that members of the Company’s Board of Directors and Management participated in the Company’s Private Placement and purchased a total of 77,660 shares at NOK 2.35 per share.

• Deputy Chairman Øystein Soug purchased 27,660 shares through his Company Abakus Invest AS and controls after the transaction a total of 107,205 shares in the Company
• CEO Anker Lundemose purchased 25,000 shares and controls after the transaction a total of 125,000 shares in the Company
• CFO Synne H. Røine purchased 25,000 shares and controls after the transaction a total of 50,000 shares in the Company 

This information is subject of the disclosure requirements acc. to §5-12 vphl(Norwegian Securities Trading Act).

Bionor Pharma ASA 
Synne H Røine
CFO
Tel +47 99 22 98 92